Fox Chase Cancer Center’s Cancer Epigenetics Institute to Present Data From Ongoing Collaboration at biomodal Workshop at AACR Annual Meeting
The Cancer Epigenetics Institute (CEI) at Fox Chase Cancer Center will present new data at a workshop sponsored by biomodal, an omics-based life sciences technology and analytics company, during the American Association for Cancer Research (AACR) Annual Meeting, which is being held April 25-30 in Chicago.